SAB BIOTHERAPEUTICS INC

$SABS
← All companies Sign in to track
Institutional coverage

67 13F filers hold $SABS.

13F holders
67
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

3 holders · Q1 2026

$SABS is held by 3 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.27%, with an average of 0.15% of portfolio. Largest holder: Fidelis Capital Partners, LLC at 0.27%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

01
Fidelis Capital Partners, LLC
0.27% NEW
α +19.5pts
02
Soleus Capital Management, L.P.
0.16% NEW
α +16.0pts
03
Citigroup Inc.
0.00% held
α +26.3pts

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 67 · Source: 13F-HR
01
Vivo Capital, LLC
3.64% of portfolio
11,420,000 sh
02
Mint Tower Capital Management B.V.
3.65% of portfolio
11,420,000 sh
03
Cahaba Wealth Management, Inc.
2.03% of portfolio
7,967,207 sh
04
Vernal Point Advisors, LLC
0.98% of portfolio
4,401,500 sh
05
Siemens Pension Trust E V
0.02% of portfolio
3,760,439 sh
06
Partners Value Investments L.P.
0.02% of portfolio
3,405,553 sh
07
Evergreen Capital Management LLC
—
3,032,697 sh
08
Callan Capital, LLC
0.08% of portfolio
2,963,320 sh
09
Jupiter Wealth Management LLC
0.04% of portfolio
2,851,791 sh
10
Teton Advisors, Inc.
0.01% of portfolio
2,751,220 sh
See all 67 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $SABS in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $SABS in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 09:50 UTC.